Description
PLASMAPHERSIS DC VAMC
First action · last action
2023-11-29 · 2025-07-10
Transactions
3
First transaction's obligation
$57,668
Base + all options value (sum of deltas)
$57,284
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
622110 · GENERAL MEDICAL AND SURGICAL HOSPITALS
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-11-29+$57,668= $57,668
- Mod P000012024-11-29+$28,834= $86,502
- Mod P000022025-07-10-$29,218= $57,284
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-11-29 | +$57,668 | $57,668 | PLASMAPHERSIS DC VAMC |
| Mod P00001· FUNDING ONLY ACTION | 2024-11-29 | +$28,834 | $86,502 | PLASMAPHERSIS DC VAMC |
| Mod P00002· FUNDING ONLY ACTION | 2025-07-10 | −$29,218 | $57,284 | PLASMAPHERSIS DC VAMC |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GKT4L2JZJ622)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026D0056 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q515 · MEDICAL- PATHOLOGY | $0 | FY2026 |
| 36C26026N0391 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q515 · MEDICAL- PATHOLOGY | $70,000 | FY2026 |
| 36C24426N0344 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS | $1,682,246 | FY2026 |
| 36C24426D0025 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C24426N0788 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q999 · MEDICAL- OTHER | $56,268 | FY2026 |
| 36C26126N0359 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $123,337 | FY2026 |
Other recipients under Q508 from 245-NETWORK CONTRACT OFFICE 5 (36C245) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24520C0089 | CHG COMPANIES, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $360,229 | FY2020 |
| 36C24519C0235 | BIO-MEDICAL APPLICATIONS OF MARYLAND, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $240,000 | FY2019 |
| 36C24519C0031 | BIO-MEDICAL APPLICATIONS OF MARYLAND, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $1,093,322 | FY2019 |
| 36C24519F0067 | AMERICAN NATIONAL RED CROSS, THE | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $146,879 | FY2019 |
| 36C24519C0033 | ITXM DIAGNOSTICS, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $127,274 | FY2019 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24524C0175_3600_-NONE-_-NONE- · retrieved 2026-09-26.